Resources
Filter by Topic
MMIT/Evaluate Acquire Panalgo to Bring Speed and Trust to Pharma Analytics and Decision-Making
September 28, 2021, Yardley, PA – Managed Markets Insight & Technology (MMIT) and Evaluate (a Welsh, Carson, Anderson & Stowe and Hg portfolio company)—which joined
RWE: Supporting Regulatory Submissions with Real-World Evidence
In this article with HIT Consultant, Tiffany Siu Woodworth, Director of Analytics Solutions at Panalgo, discusses RWE within the regulatory landscape. She notes how in
The IMPact of untReated nOn-Valvular atrial fibrillation on short-tErm clinical and economic outcomes in the US Medicare population: the IMPROVE-AF model
Click here for the publication.
Podium and Posters from ICPE 2021
PODIUM PRESENTATION: Predictors of Severe COVID-19 Outcomes in Patients with Rheumatoid Arthritis Presented by Sara Burns SPOTLIGHT POSTER: Factors Associated with Initiation of Oral vs.
Leveraging RWD in Observational Studies: Understanding the Implications of Time-Related Biases
Dr. Suissa spoke at Panalgo’s 2021 IHD User conference about the implications of relying on observational studies that may have time-related biases and how to
Innovating RWE Organizations: Learning from the Past and Looking to the Future
Chris spoke at Panalgo’s 2021 IHD User conference about the evolution of Real-World Evidence (RWE) and how pharma needs to reimagine its function – to
IHD Analytics
Put reliable, rapid analytics in the hands of more people across your organization